Cargando…
The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy
The growth and metastasising capacity of solid tumours are dependent on angiogenesis. Vascular endothelial growth factor is a mediator of angiogenesis. In this study we investigated whether vascular endothelial growth factor is associated with the natural course of the disease in primary invasive br...
Autores principales: | Manders, P, Beex, L V A M, Tjan-Heijnen, V C G, Geurts-Moespot, J, Van Tienoven, T H, Foekens, J A, Sweep, C G J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364266/ https://www.ncbi.nlm.nih.gov/pubmed/12232762 http://dx.doi.org/10.1038/sj.bjc.6600555 |
Ejemplares similares
-
Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome
por: Span, P N, et al.
Publicado: (2003) -
Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen
por: Coradini, D, et al.
Publicado: (2003) -
Prognostic significance of the sequential detection of circulating melanoma cells by RT–PCR in high-risk melanoma patients receiving adjuvant interferon
por: Gogas, H, et al.
Publicado: (2002) -
An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation
por: Cascinu, S, et al.
Publicado: (2002) -
Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours
por: Witte, J H de, et al.
Publicado: (2001)